Inventor · disambiguated record
Martin Kleinschmidt
Also filed as: KLEINSCHMIDT MARTIN
9 granted patents·9 pending applications·41 citations·filing 2009–2023
81Inventor score
Files withPROBIODRUG AG11DEMUTH HANS-ULRICH2FRAUNHOFER GES FORSCHUNG2FORSCHUNGSZENTRUM JUELICH GMBH1KLEINSCHMIDT MARTIN1
Top patents by PatentIndex Score
18 records- 0192US8058405B2Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptidesDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 15, 2011·38 cites·28 claims
- 0285US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 0369US2010028918A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 0467US11045533B2Humanized antibodiesPROBIODRUG AG·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 0561US8809508B2Diagnostic antibody assayKLEINSCHMIDT MARTIN·Filed 2012·Granted Aug 19, 2014·1 cites·10 claims
- 0660US2025163136A1Anti-transthyretin (ttr) binding proteins and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2023·Application pending·0 cites
- 0757US2017097365A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2016·Application pending·0 cites
- 0854US9657089B2Diagnostic antibody assayPROBIODRUG AG·Filed 2014·Granted May 23, 2017·0 cites·20 claims
- 0954US2025057802A1Broad-spectrum antiviral drugsFRAUNHOFER GES FORSCHUNG·Filed 2022·Application pending·0 cites
- 1053US2015247180A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 1152US9156907B2Diagnostic antibody assayDEMUTH HANS-ULRICH·Filed 2011·Granted Oct 13, 2015·0 cites·50 claims
- 1249US12043659B2Humanized and de-immunized antibodiesVIVORYON THERAPEUTICS N V·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
- 1348US9676843B2Uses of antibodies directed against amyloid-βPROBIODRUG AG·Filed 2015·Granted Jun 13, 2017·0 cites·26 claims
- 1440US9611296B2Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptidesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Apr 4, 2017·0 cites·16 claims
- 1540US2011166035A1Novel diagnostic methodPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 1640US2011091910A1Novel assayPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 1738US2017363645A1Novel Method for the Detection of pGlu-Abeta PeptidesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 1836US2011212853A1Novel diagnostic methodPROBIODRUG AG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Kleinschmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →